BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260506
DTEND;VALUE=DATE:20260508
DTSTAMP:20260519T224927
CREATED:20260105T213349Z
LAST-MODIFIED:20260105T213358Z
UID:10000557-1778025600-1778198399@oncodaily.com
SUMMARY:Advances in Cell-based Screening 2026
DESCRIPTION:The 6th ELRIG Advances in Cell-based Screening 2026 is a free-to-attend\, two-day scientific conference scheduled for May 6–7\, 2026\, in Gothenburg\, Sweden. \nHosted at the AstraZeneca R&D site\, this interactive event brings together biologists and chemists from academia and industry to explore the latest advancements in cell-based assays. The technical program focuses on state-of-the-art screening formats and best practices for target identification\, target validation\, and compound optimization. \nWhile applicable across many therapeutic areas\, the methodologies discussed – such as high-content imaging and complex 3D cellular models – are foundational to modern oncology drug discovery and precision medicine research. \nRegister.
URL:https://oncodaily.com/event/cell-based-screening-437189
LOCATION:AstraZeneca R&D Gothenburg\, Pepparedsleden 1\, Mölndal\, Västra Götaland\, 431 50\, Sweden
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Advances-in-Cell-based-Screening-1.webp
ORGANIZER;CN="European Laboratory Research and Innovation Group (ELRIG)":MAILTO:info@elrig.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260309
DTEND;VALUE=DATE:20260311
DTSTAMP:20260519T224927
CREATED:20260105T212607Z
LAST-MODIFIED:20260105T212616Z
UID:10000556-1773014400-1773187199@oncodaily.com
SUMMARY:Cell and Gene Therapy 2026
DESCRIPTION:The ELRIG Cell and Gene Therapy 2026 is a free-to-attend\, two-day scientific conference scheduled for March 9–10\, 2026\, in Cambridge\, UK. \nOrganized by the European Laboratory Research and Innovation Group (ELRIG)\, this event focuses on the translational journey of advanced therapies from preclinical innovation to clinical application. The technical program features four key tracks: gene therapies for neurological disorders\, advancements in sensory disorder treatments\, scaling solutions for rare diseases\, and next-generation cancer immunotherapy. \nThe oncology-specific track\, titled “Engineering the Future of Cancer Immunotherapy: Advances in T Cell Design and Function\,” explores cutting-edge developments in CAR and TCR engineering\, strategies to improve the safety and durability of T-cell therapies\, and technologies aimed at making these treatments more accessible for both hematological and solid malignancies. \nRegister.
URL:https://oncodaily.com/event/cell-and-gene-therapy-437178
LOCATION:Hinxton Hall Conference Centre\, Wellcome Genome Campus\, Hinxton\, Cambridge\, Cambridgeshire\, CB10 1RQ\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Cell-and-Gene-Therapy-1.webp
ORGANIZER;CN="European Laboratory Research and Innovation Group (ELRIG)":MAILTO:info@elrig.org
END:VEVENT
END:VCALENDAR